FHI 360 is an international nonprofit that works to improve the health of people around the world. In China, FHI 360 works closely with the government to address health and development issues.
Projects
2013 - 2016: Aspirin in Treating Patients with Colon Cancer. Active in five sites in China, funded by the National Cancer Center Singapore.
2012 - 2014: China Adherence through Technology Study (CATS). Carried out through partnership with a local HIV clinic in Guangxi. Funded by Trustees of Boston University, Boston University Medical Campus.
2011 - 2017: Control and Prevention of Tuberculosis (CAP-TB) Funded by USAID/Regional Development Mission for Asia. This project was also carried out in Laos, Myanmar (Burma), Papua New Guinea and Thailand.
2011 - 2018: HIV Clinical Research Support Services (CRSS). Funded by NIH, carried out around the world.
2010 - 2011: Eliminate Dengue. Funded by Bill & Melinda Gates Foundation.
Regional Prospective Observational Research in Tuberculosis (RePORT) International Coordinating Center. Funded by U.S. National Institutes of Health.
Ongoing: China Tuberculosis Clinical Trials Consortium (CTCTC) project. Funded by U.S. National Institutes of Health.
Contact Details
Jacqueline McPherson
jmcpherson@fhi360.org
+86. 108.588.5599,+86.871.363.3280
https://www.fhi360.org/countries/china
Beijing Representative Office, B110, Floor 4, Building 1, No. 15, Guang Hua Road, Chao Yang District, Beijing, China 100026
FHI 360 Kunming Office, #1302B, Jin Tai Plaza, #48 East Dong Feng Road, Kunming 650051 China
